These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20689331)

  • 1. Erythropoietin protects podocytes from damage by advanced glycation end-products.
    Ruester C; Franke S; Bondeva T; Wolf G
    Nephron Exp Nephrol; 2011; 117(1):e21-30. PubMed ID: 20689331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin ameliorates podocyte injury in advanced diabetic nephropathy in the db/db mouse.
    Loeffler I; Rüster C; Franke S; Liebisch M; Wolf G
    Am J Physiol Renal Physiol; 2013 Sep; 305(6):F911-8. PubMed ID: 23825071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes.
    Rüster C; Bondeva T; Franke S; Förster M; Wolf G
    Nephrol Dial Transplant; 2008 Jul; 23(7):2179-91. PubMed ID: 18344241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end products suppress neuropilin-1 expression in podocytes by a reduction in Sp1-dependent transcriptional activity.
    Bondeva T; Wolf G
    Am J Nephrol; 2009; 30(4):336-45. PubMed ID: 19590177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation end products inhibit adhesion ability of differentiated podocytes in a neuropilin-1-dependent manner.
    Bondeva T; Wojciech S; Wolf G
    Am J Physiol Renal Physiol; 2011 Oct; 301(4):F852-70. PubMed ID: 21734098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end-products suppress neuropilin-1 expression in podocytes.
    Bondeva T; Rüster C; Franke S; Hammerschmid E; Klagsbrun M; Cohen CD; Wolf G
    Kidney Int; 2009 Mar; 75(6):605-16. PubMed ID: 19037249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the receptor for advanced glycation end products induces nuclear inhibitor of protein phosphatase-1 suppression.
    Liebisch M; Bondeva T; Franke S; Daniel C; Amann K; Wolf G
    Kidney Int; 2014 Jul; 86(1):103-17. PubMed ID: 24476693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone-related protein induces hypertrophy in podocytes via TGF-beta(1) and p27(Kip1): implications for diabetic nephropathy.
    Romero M; Ortega A; Izquierdo A; López-Luna P; Bosch RJ
    Nephrol Dial Transplant; 2010 Aug; 25(8):2447-57. PubMed ID: 20200004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ezrin contributes to impaired podocyte migration and adhesion caused by advanced glycation end products.
    McRobert EA; Bach LA
    Nephrology (Carlton); 2016 Jan; 21(1):13-20. PubMed ID: 26032400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin prevents diabetes-induced podocyte damage.
    Schiffer M; Park JK; Tossidou I; Bartels J; Shushakova N; Menne J; Fliser D
    Kidney Blood Press Res; 2008; 31(6):411-5. PubMed ID: 19096223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UCH-L1 induces podocyte hypertrophy in membranous nephropathy by protein accumulation.
    Lohmann F; Sachs M; Meyer TN; Sievert H; Lindenmeyer MT; Wiech T; Cohen CD; Balabanov S; Stahl RA; Meyer-Schwesinger C
    Biochim Biophys Acta; 2014 Jul; 1842(7):945-58. PubMed ID: 24583340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
    Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
    Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor.
    Chuang PY; Yu Q; Fang W; Uribarri J; He JC
    Kidney Int; 2007 Oct; 72(8):965-76. PubMed ID: 17667983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.
    Xu ZG; Yoo TH; Ryu DR; Cheon Park H; Ha SK; Han DS; Adler SG; Natarajan R; Kang SW
    Kidney Int; 2005 Mar; 67(3):944-52. PubMed ID: 15698433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth arrest specific 2-like protein 1 expression is upregulated in podocytes through advanced glycation end-products.
    Liebisch M; Bondeva T; Franke S; Hause S; Wolf G
    Nephrol Dial Transplant; 2017 Apr; 32(4):641-653. PubMed ID: 27638909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D3 Partly Antagonizes Advanced-Glycation Endproducts-Induced NFκB Activation in Mouse Podocytes.
    Rüster C; Franke S; Reuter S; Mrowka R; Bondeva T; Wolf G
    Nephron; 2016; 134(2):105-116. PubMed ID: 27505422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II upregulates RAGE expression on podocytes: role of AT2 receptors.
    Rüster C; Bondeva T; Franke S; Tanaka N; Yamamoto H; Wolf G
    Am J Nephrol; 2009; 29(6):538-50. PubMed ID: 19129693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protective effects of erythropoietin on rat glomerular podocytes in culture are modulated by extracellular matrix proteins.
    Krtil J; Pláteník J; Čuřík N; Brima W; Tesař V; Zima T
    Kidney Blood Press Res; 2013; 38(1):142-55. PubMed ID: 24685986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-9 inhibits glomerular hypertrophy in db/db diabetic mice via cell-cycle-dependent mechanisms.
    Baba M; Wada J; Eguchi J; Hashimoto I; Okada T; Yasuhara A; Shikata K; Kanwar YS; Makino H
    J Am Soc Nephrol; 2005 Nov; 16(11):3222-34. PubMed ID: 16177004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo.
    Logar CM; Brinkkoetter PT; Krofft RD; Pippin JW; Shankland SJ
    Kidney Int; 2007 Aug; 72(4):489-98. PubMed ID: 17554257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.